Trial · NCT03774810
Participant flow45
How many started, completed or left each group, period by period.
1 to 20 of 45
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Phase 1 | STARTED | QHS-FD (Phase 1) | 115 | |
| Phase 1 | STARTED | Partial Reinforcement 1 (PR1) (Phases 2 & 3) | 0 | |
| Phase 1 | STARTED | Partial Reinforcement 3 (PR3) (Phases 2 & 3) | 0 | |
| Phase 1 | STARTED | Low Frequency Intermittent Dosing (IDS-FD) (Phases 2 & 3) | 0 | |
| Phase 1 | STARTED | Full Dose Nightly (QHS-FD) (Phases 2 & 3) | 0 | |
| Phase 1 | COMPLETED | QHS-FD (Phase 1) | 83 | |
| Phase 1 | COMPLETED | Partial Reinforcement 1 (PR1) (Phases 2 & 3) | 0 | |
| Phase 1 | COMPLETED | Partial Reinforcement 3 (PR3) (Phases 2 & 3) | 0 | |
| Phase 1 | COMPLETED | Low Frequency Intermittent Dosing (IDS-FD) (Phases 2 & 3) | 0 | |
| Phase 1 | COMPLETED | Full Dose Nightly (QHS-FD) (Phases 2 & 3) | 0 | |
| Phase 1 | NOT COMPLETED | QHS-FD (Phase 1) | 32 | |
| Phase 1 | NOT COMPLETED | Partial Reinforcement 1 (PR1) (Phases 2 & 3) | 0 | |
| Phase 1 | NOT COMPLETED | Partial Reinforcement 3 (PR3) (Phases 2 & 3) | 0 | |
| Phase 1 | NOT COMPLETED | Low Frequency Intermittent Dosing (IDS-FD) (Phases 2 & 3) | 0 | |
| Phase 1 | NOT COMPLETED | Full Dose Nightly (QHS-FD) (Phases 2 & 3) | 0 | |
| Phase 2 (3 Months) | STARTED | QHS-FD (Phase 1) | 0 | |
| Phase 2 (3 Months) | STARTED | Partial Reinforcement 1 (PR1) (Phases 2 & 3) | 22 | |
| Phase 2 (3 Months) | STARTED | Partial Reinforcement 3 (PR3) (Phases 2 & 3) | 18 | |
| Phase 2 (3 Months) | STARTED | Low Frequency Intermittent Dosing (IDS-FD) (Phases 2 & 3) | 23 | |
| Phase 2 (3 Months) | STARTED | Full Dose Nightly (QHS-FD) (Phases 2 & 3) | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03774810/flow